IDEX Corporation (IEX)
NYSE: IEX · Real-Time Price · USD
159.12
-4.39 (-2.68%)
At close: Aug 1, 2025, 4:00 PM
158.90
-0.22 (-0.14%)
After-hours: Aug 1, 2025, 7:24 PM EDT
Singular Genomics Systems Stock Forecast
Stock Price Forecast
The 7 analysts that cover Singular Genomics Systems stock have a consensus rating of "Buy" and an average price target of $216.86, which forecasts a 36.29% increase in the stock price over the next year. The lowest target is $200 and the highest is $241.
Price Target: $216.86 (+36.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Singular Genomics Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $207 → $200 | Buy | Maintains | $207 → $200 | +25.69% | Jul 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $238 → $204 | Strong Buy | Maintains | $238 → $204 | +28.21% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $224 → $212 | Buy | Maintains | $224 → $212 | +33.23% | Jul 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $208 → $238 | Strong Buy | Maintains | $208 → $238 | +49.57% | Jul 21, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $208 → $216 | Strong Buy | Maintains | $208 → $216 | +35.75% | Jul 14, 2025 |
Financial Forecast
Revenue This Year
3.46B
from 3.27B
Increased by 5.97%
Revenue Next Year
3.60B
from 3.46B
Increased by 4.04%
EPS This Year
8.28
from 6.64
Increased by 24.75%
EPS Next Year
8.95
from 8.28
Increased by 8.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7B | 3.8B | 4.2B | ||
| Avg | 3.5B | 3.6B | 3.8B | ||
| Low | 3.3B | 3.4B | 3.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.7% | 9.8% | 17.3% | ||
| Avg | 6.0% | 4.0% | 6.1% | ||
| Low | 1.4% | -2.7% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.75 | 9.56 | 10.64 | ||
| Avg | 8.28 | 8.95 | 9.64 | ||
| Low | 7.89 | 8.14 | 8.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.7% | 15.4% | 18.8% | ||
| Avg | 24.7% | 8.1% | 7.7% | ||
| Low | 18.8% | -1.8% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.